Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Neurology
Clinical Trials: Brain Cancer
A listing of clinical trials currently looking for volunteers to enroll in Brain Cancer studies. Click on the closest city to find more detailed information on a research study in your area.
California
Duarte : City of Hope Updated New
A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme
Duarte : City of Hope Updated
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Duarte : City of Hope Updated
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination with Interleukin-2
Duarte : City of Hope Updated
RTOG 0539: Phase II Trial of Observation for Low-Risk Meningiomas and of Radiotherapy for Intermediate and High Risk Meningiomas
Duarte : City of Hope Updated New
RTOG 0929: A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma
View More »
Duarte : City of Hope Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
La Jolla : UCSD Moores Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Los Angeles : UCLA Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Newport Beach : Hoag Memorial Hospital Presbyterian Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Newport Beach : Hoag Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Sacramento : Sutter Institute for Medical Research Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
South Pasadena : South Pasadena Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Florida
Miami Beach : Mount Sinai CCOP Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Illinois
Chicago : Rush University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Chicago : University of Illinois Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Peoria : Illinois Cancer Care Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Indiana
Indianapolis : IU Simon Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Massachusetts
Boston : Tufts Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Michigan
Ann Arbor : University of Michigan, Department of Neurosurgery Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Detroit : Henry Ford Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Minnesota
Minneapolis : Virginia Piper Cancer Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Missouri
Kansas City : St. Luke's Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
St. Louis : Washington University School of Medicine Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New Jersey
Basking Ridge : Memorial Sloan-Kettering at Basking Ridge
EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation
Basking Ridge : Memorial Sloan-Kettering at Basking Ridge
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Summit : Overlook Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Summit : Overlook Hospital
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
New York
Commack : Memorial Sloan-Kettering Cancer Center at Commack
EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation
Commack : Memorial Sloan-Kettering Cancer Center at Commack
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Commack, Great Neck : Long Island Brain Tumor Centre at Neurological Surgery P.C. Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Huntington : Huntington Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Manhasset : North Shore University Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
View More »
Mineola : Winthrop University Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : Memorial Sloan Kettering Cancer Center
EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation
New York : Memorial Sloan Kettering Cancer Center
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
New York : New York University Clinical Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
New York : New York University Clinical Cancer Center
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Oceanside : South Nassau Community Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rochester : University of Rochester Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rockville Centre : Mercy Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
North Carolina
Chapel Hill : University of North Carolina Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Durham : Duke University Medical Center
Aloxi for Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Malignant Glioma (MG) Patients Receiving Irinotecan With Bevacizumab
Ohio
Cincinnati : UC Cancer Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : Cleveland Clinic Foundation Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Cleveland : University Hospitals of Cleveland Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Rhode Island
Providence : Rhode Island Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
South Carolina
Tennessee
Nashville : Sarah Cannon Research Institute
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
Nashville : St. Thomas Hospital Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Nashville : Vanderbilt Ingram Cancer Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Texas
Houston : S. R. Burzynski Clinic
A phase II BT-6 study of Antyneoplastons A10 and AS2-1 Infusions in Children with High Grade Glioma
Houston : S. R. Burzynski Clinic
A phase II study demonstrate the anti-tumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with Primitive neuroectodermal tumors by determining the proportion of patients who experience an objective tumor responses.
Houston : S. R. Burzynski Clinic
A phase II study demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with low grade astrocytoma by determining the proportion of patients who experience an objective tumor responses
Houston : S. R. Burzynski Clinic
A phase II study demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with rhabdoid tumor of the central nervous system by determining the proportion of patients who experience an objective tumor responses
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2 1 In Patients With Glioblastoma Multiforme
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Children With Visual Pathway Glioma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 and AS2-1 in adult patients with Anaplastic Astrocytoma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Glioblastoma Multiforme
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Low Grade Astrocytoma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Meningioma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Mixed Glioma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Oligodendroglioma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Primary Malignant Brain Tumor
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 and AS2-1 in Patients with Anaplastic Astrocytoma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Patients With Brain Tumors
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Infusions Private In Patients With Choroid Plexus Neoplasm
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Infusions Private In Patients With Germ Cell Tumor Of The Brain
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Children With Primary Malignant Brain Tumors
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Craniopharyngioma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Ependymoma
Houston : S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Neurofibroma And Schwannoma
Houston : S. R. Burzynski Clinic
A phase II study to demonstrate the anti-tumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with brain tumors by determining the proportion of patients who experience an objective tumor response
Houston : S. R. Burzynski Clinic
A phase II study to demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of patients with brain stem glioma by determining the proportion of patients who experience an objective tumor response.
View More »
Dallas : Baylor Research Institute Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Houston : UT MD Anderson Cancer Center
Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
Houston : UT MD Anderson Cancer Center
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Washington
Seattle : Swedish Hospital Neuroscience Research Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
United States
Washington : Georgetown University Medical Center Updated
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
